Summary

Global infertility treatment market to reach USD 2.4 billion by 2027.
Global infertility treatment market is valued approximately at USD 1.4 billion in 2020 and is anticipated to grow with a healthy growth rate of about 8.1% over the forecast period 2021-2027. Infertility treatment deals with the adoption of different techniques and procedures to treat infertility which may be caused as a result of disorders related to occurrence of ovulation, maternal age, sextually transmitted infections, tubal occlusion or blockage, genetics, immune infertility, and others. The global infertility treatment market is being driven by declining fertility rate and increasing public-private investments, funds, and grants. Furthermore, increasing medical tourism due to low treatment costs will provide new opportunities for the global infertility treatment industry. Market players across the globe are undertaking a range of strategic initiatives which is expected to have a positive impact on the market growth. For instance, in 2021, CooperSurgical partnered with Virtus Health in order to strengthen its fertility technology. This would increase the accessibility of advanced treatment methods to infertile couples. Also, in 2021, Hamilton Thorne Ltd. received approval from the Food and Drug Administration for the commercialization of GYNEMED GM501. It is a ready-to-use medium, which is designed for in vitro handling and washing procedures of human embryos and oocytes in the United States and Europe. Such strategic initiatives taken by the market players across the globe is expected to increase the adoption of infertility treatment methods and hence promote the market growth. However, high costs associated with assisted reproductive technology may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global infertility treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific accounts for the largest share in terms of market revenue in the global infertility treatment market over the forecast period 2021-2027. Factors such as rise in medical tourism, growth in the awareness regarding availability of infertility treatment procedures, rising healthcare expenditures, growing fertility centers, increasing rate of infertility, government initiatives to increase infertility treatment accessibility, etc. contribute towards the largest market share of the region in the forecast years.

Major market player included in this report are:
The Cooper Companies Inc.
Cook Group
Vitrolife
Thermo Fisher Scientific, Inc.
Esco Micro Pte. Ltd.
Genea Biomedx
IVFtech ApS
FUJIFILM Irvine Scientific
The Baker Company, Inc.
Kitazato Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Equipment
Media & Consumables
Accessories
By Procedure:
Assisted Reproductive Technology
Artificial Insemination
Fertility Surgeries
Other Infertility Treatment Procedures
By Patient Type:
Female Infertility Treatment
Male Infertility Treatment
By End User:
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Infertility Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Infertility Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Infertility Treatment Market, by Product, 2019-2027 (USD Billion)
1.2.3. Infertility Treatment Market, by Procedure, 2019-2027 (USD Billion)
1.2.4. Infertility Treatment Market, by Patient Type, 2019-2027 (USD Billion)
1.2.5. Infertility Treatment Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infertility Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infertility Treatment Market Dynamics
3.1. Infertility Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Declining fertility rate
3.1.1.2. Increasing public-private investments, funds, and grants
3.1.2. Market Restraint
3.1.2.1. High costs associated with assisted reproductive technology
3.1.3. Market Opportunities
3.1.3.1. Increasing medical tourism due to low treatment costs
Chapter 4. Global Infertility Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Infertility Treatment Market, by Product
5.1. Market Snapshot
5.2. Global Infertility Treatment Market by Product, Performance - Potential Analysis
5.3. Global Infertility Treatment Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. Infertility Treatment Market, Sub Segment Analysis
5.4.1. Equipment
5.4.2. Media & Consumables
5.4.3. Accessories
Chapter 6. Global Infertility Treatment Market, by Procedure
6.1. Market Snapshot
6.2. Global Infertility Treatment Market by Procedure, Performance - Potential Analysis
6.3. Global Infertility Treatment Market Estimates & Forecasts by Procedure 2018-2027 (USD Billion)
6.4. Infertility Treatment Market, Sub Segment Analysis
6.4.1. Assisted Reproductive Technology
6.4.2. Artificial Insemination
6.4.3. Fertility Surgeries
6.4.4. Other Infertility Treatment Procedures
Chapter 7. Global Infertility Treatment Market, by Patient Type
7.1. Market Snapshot
7.2. Global Infertility Treatment Market by Patient Type, Performance - Potential Analysis
7.3. Global Infertility Treatment Market Estimates & Forecasts by Patient Type 2018-2027 (USD Billion)
7.4. Infertility Treatment Market, Sub Segment Analysis
7.4.1. Female Infertility Treatment
7.4.2. Male Infertility Treatment
Chapter 8. Global Infertility Treatment Market, by End User
8.1. Market Snapshot
8.2. Global Infertility Treatment Market by End User, Performance - Potential Analysis
8.3. Global Infertility Treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
8.4. Infertility Treatment Market, Sub Segment Analysis
8.4.1. Fertility Centers
8.4.2. Hospitals & Surgical Clinics
8.4.3. Cryobanks
8.4.4. Research Institutes
Chapter 9. Global Infertility Treatment Market, Regional Analysis
9.1. Infertility Treatment Market, Regional Market Snapshot
9.2. North America Infertility Treatment Market
9.2.1. U.S. Infertility Treatment Market
9.2.1.1. Product breakdown estimates & forecasts, 2018-2027
9.2.1.2. Procedure breakdown estimates & forecasts, 2018-2027
9.2.1.3. Patient Type breakdown estimates & forecasts, 2018-2027
9.2.1.4. End User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Infertility Treatment Market
9.3. Europe Infertility Treatment Market Snapshot
9.3.1. U.K. Infertility Treatment Market
9.3.2. Germany Infertility Treatment Market
9.3.3. France Infertility Treatment Market
9.3.4. Spain Infertility Treatment Market
9.3.5. Italy Infertility Treatment Market
9.3.6. Rest of Europe Infertility Treatment Market
9.4. Asia-Pacific Infertility Treatment Market Snapshot
9.4.1. China Infertility Treatment Market
9.4.2. India Infertility Treatment Market
9.4.3. Japan Infertility Treatment Market
9.4.4. Australia Infertility Treatment Market
9.4.5. South Korea Infertility Treatment Market
9.4.6. Rest of Asia Pacific Infertility Treatment Market
9.5. Latin America Infertility Treatment Market Snapshot
9.5.1. Brazil Infertility Treatment Market
9.5.2. Mexico Infertility Treatment Market
9.6. Rest of The World Infertility Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. The Cooper Companies Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Cook Group
10.2.3. Vitrolife
10.2.4. Thermo Fisher Scientific, Inc.
10.2.5. Esco Micro Pte. Ltd.
10.2.6. Genea Biomedx
10.2.7. IVFtech ApS
10.2.8. FUJIFILM Irvine Scientific
10.2.9. The Baker Company, Inc.
10.2.10. Kitazato Corporation
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption